Drug Eluting Beads Industry Research Report 2025
Description
Summary
According to APO Research, the global Drug Eluting Beads market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Drug Eluting Beads include Medtronic, Terumo, Surefire Medical, Merit Medical Systems, Merit Medical Systems, CeloNova BioSciences, BTG International, Boston Scientific and Biocompatibles, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads.
The report will help the Drug Eluting Beads manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Drug Eluting Beads market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Beads market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Drug Eluting Beads Segment by Company
Medtronic Terumo Surefire Medical Merit Medical Systems Merit Medical Systems CeloNova BioSciences BTG International Boston Scientific Biocompatibles ABK BiomedicalDrug Eluting Beads Segment by Type
LC Beads Quadra Sphere Oncozene Beads OthersDrug Eluting Beads Segment by Application
Specialized Clinics Hospitals Research Centers Ambulatory Surgical CentersDrug Eluting Beads Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Beads market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Eluting Beads and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Beads.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Eluting Beads by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Drug Eluting Beads market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Drug Eluting Beads is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Drug Eluting Beads include Medtronic, Terumo, Surefire Medical, Merit Medical Systems, Merit Medical Systems, CeloNova BioSciences, BTG International, Boston Scientific and Biocompatibles, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads.
The report will help the Drug Eluting Beads manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Drug Eluting Beads market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Beads market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Drug Eluting Beads Segment by Company
Medtronic Terumo Surefire Medical Merit Medical Systems Merit Medical Systems CeloNova BioSciences BTG International Boston Scientific Biocompatibles ABK BiomedicalDrug Eluting Beads Segment by Type
LC Beads Quadra Sphere Oncozene Beads OthersDrug Eluting Beads Segment by Application
Specialized Clinics Hospitals Research Centers Ambulatory Surgical CentersDrug Eluting Beads Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Beads market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Eluting Beads and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Beads.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Eluting Beads by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
129 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drug Eluting Beads Market Size (2020-2031)
- 2.2.2 Global Drug Eluting Beads Sales (2020-2031)
- 2.2.3 Global Drug Eluting Beads Market Average Price (2020-2031)
- 2.3 Drug Eluting Beads by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 LC Beads
- 2.3.3 Quadra Sphere
- 2.3.4 Oncozene Beads
- 2.3.5 Others
- 2.4 Drug Eluting Beads by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Specialized Clinics
- 2.4.3 Hospitals
- 2.4.4 Research Centers
- 2.4.5 Ambulatory Surgical Centers
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug Eluting Beads Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Drug Eluting Beads Sales (k units) of Manufacturers (2020-2025)
- 3.3 Global Drug Eluting Beads Revenue of Manufacturers (2020-2025)
- 3.4 Global Drug Eluting Beads Average Price by Manufacturers (2020-2025)
- 3.5 Global Drug Eluting Beads Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drug Eluting Beads, Product Type & Application
- 3.8 Global Manufacturers of Drug Eluting Beads, Established Date
- 3.9 Global Drug Eluting Beads Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Medtronic Drug Eluting Beads Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Terumo
- 4.2.1 Terumo Company Information
- 4.2.2 Terumo Business Overview
- 4.2.3 Terumo Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Terumo Drug Eluting Beads Product Portfolio
- 4.2.5 Terumo Recent Developments
- 4.3 Surefire Medical
- 4.3.1 Surefire Medical Company Information
- 4.3.2 Surefire Medical Business Overview
- 4.3.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Surefire Medical Drug Eluting Beads Product Portfolio
- 4.3.5 Surefire Medical Recent Developments
- 4.4 Merit Medical Systems
- 4.4.1 Merit Medical Systems Company Information
- 4.4.2 Merit Medical Systems Business Overview
- 4.4.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
- 4.4.5 Merit Medical Systems Recent Developments
- 4.5 Merit Medical Systems
- 4.5.1 Merit Medical Systems Company Information
- 4.5.2 Merit Medical Systems Business Overview
- 4.5.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
- 4.5.5 Merit Medical Systems Recent Developments
- 4.6 CeloNova BioSciences
- 4.6.1 CeloNova BioSciences Company Information
- 4.6.2 CeloNova BioSciences Business Overview
- 4.6.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 CeloNova BioSciences Drug Eluting Beads Product Portfolio
- 4.6.5 CeloNova BioSciences Recent Developments
- 4.7 BTG International
- 4.7.1 BTG International Company Information
- 4.7.2 BTG International Business Overview
- 4.7.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 BTG International Drug Eluting Beads Product Portfolio
- 4.7.5 BTG International Recent Developments
- 4.8 Boston Scientific
- 4.8.1 Boston Scientific Company Information
- 4.8.2 Boston Scientific Business Overview
- 4.8.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Boston Scientific Drug Eluting Beads Product Portfolio
- 4.8.5 Boston Scientific Recent Developments
- 4.9 Biocompatibles
- 4.9.1 Biocompatibles Company Information
- 4.9.2 Biocompatibles Business Overview
- 4.9.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Biocompatibles Drug Eluting Beads Product Portfolio
- 4.9.5 Biocompatibles Recent Developments
- 4.10 ABK Biomedical
- 4.10.1 ABK Biomedical Company Information
- 4.10.2 ABK Biomedical Business Overview
- 4.10.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 ABK Biomedical Drug Eluting Beads Product Portfolio
- 4.10.5 ABK Biomedical Recent Developments
- 5 Global Drug Eluting Beads Market Scenario by Region
- 5.1 Global Drug Eluting Beads Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Drug Eluting Beads Sales by Region: 2020-2031
- 5.2.1 Global Drug Eluting Beads Sales by Region: 2020-2025
- 5.2.2 Global Drug Eluting Beads Sales by Region: 2026-2031
- 5.3 Global Drug Eluting Beads Revenue by Region: 2020-2031
- 5.3.1 Global Drug Eluting Beads Revenue by Region: 2020-2025
- 5.3.2 Global Drug Eluting Beads Revenue by Region: 2026-2031
- 5.4 North America Drug Eluting Beads Market Facts & Figures by Country
- 5.4.1 North America Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Drug Eluting Beads Sales by Country (2020-2031)
- 5.4.3 North America Drug Eluting Beads Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Drug Eluting Beads Market Facts & Figures by Country
- 5.5.1 Europe Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Drug Eluting Beads Sales by Country (2020-2031)
- 5.5.3 Europe Drug Eluting Beads Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Drug Eluting Beads Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Drug Eluting Beads Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Drug Eluting Beads Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drug Eluting Beads Market Facts & Figures by Country
- 5.7.1 South America Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Drug Eluting Beads Sales by Country (2020-2031)
- 5.7.3 South America Drug Eluting Beads Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Drug Eluting Beads Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Drug Eluting Beads Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Drug Eluting Beads Sales by Type (2020-2031)
- 6.1.1 Global Drug Eluting Beads Sales by Type (2020-2031) & (k units)
- 6.1.2 Global Drug Eluting Beads Sales Market Share by Type (2020-2031)
- 6.2 Global Drug Eluting Beads Revenue by Type (2020-2031)
- 6.2.1 Global Drug Eluting Beads Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Drug Eluting Beads Revenue Market Share by Type (2020-2031)
- 6.3 Global Drug Eluting Beads Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Drug Eluting Beads Sales by Application (2020-2031)
- 7.1.1 Global Drug Eluting Beads Sales by Application (2020-2031) & (k units)
- 7.1.2 Global Drug Eluting Beads Sales Market Share by Application (2020-2031)
- 7.2 Global Drug Eluting Beads Revenue by Application (2020-2031)
- 7.2.1 Global Drug Eluting Beads Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Drug Eluting Beads Revenue Market Share by Application (2020-2031)
- 7.3 Global Drug Eluting Beads Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drug Eluting Beads Value Chain Analysis
- 8.1.1 Drug Eluting Beads Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drug Eluting Beads Production Mode & Process
- 8.2 Drug Eluting Beads Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drug Eluting Beads Distributors
- 8.2.3 Drug Eluting Beads Customers
- 9 Global Drug Eluting Beads Analyzing Market Dynamics
- 9.1 Drug Eluting Beads Industry Trends
- 9.2 Drug Eluting Beads Industry Drivers
- 9.3 Drug Eluting Beads Industry Opportunities and Challenges
- 9.4 Drug Eluting Beads Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Drug Eluting Beads Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Drug Eluting Beads Sales (k units) of Manufacturers (2020-2025)
- Table 7. Global Drug Eluting Beads Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Drug Eluting Beads Revenue of Manufacturers (2020-2025)
- Table 9. Global Drug Eluting Beads Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Drug Eluting Beads Average Price (US$/unit) of Manufacturers (2020-2025)
- Table 11. Global Drug Eluting Beads Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Drug Eluting Beads, Product Type & Application
- Table 14. Global Drug Eluting Beads Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Drug Eluting Beads by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Medtronic Company Information
- Table 19. Medtronic Business Overview
- Table 20. Medtronic Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 21. Medtronic Drug Eluting Beads Product Portfolio
- Table 22. Medtronic Recent Developments
- Table 23. Terumo Company Information
- Table 24. Terumo Business Overview
- Table 25. Terumo Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 26. Terumo Drug Eluting Beads Product Portfolio
- Table 27. Terumo Recent Developments
- Table 28. Surefire Medical Company Information
- Table 29. Surefire Medical Business Overview
- Table 30. Surefire Medical Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 31. Surefire Medical Drug Eluting Beads Product Portfolio
- Table 32. Surefire Medical Recent Developments
- Table 33. Merit Medical Systems Company Information
- Table 34. Merit Medical Systems Business Overview
- Table 35. Merit Medical Systems Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 36. Merit Medical Systems Drug Eluting Beads Product Portfolio
- Table 37. Merit Medical Systems Recent Developments
- Table 38. Merit Medical Systems Company Information
- Table 39. Merit Medical Systems Business Overview
- Table 40. Merit Medical Systems Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 41. Merit Medical Systems Drug Eluting Beads Product Portfolio
- Table 42. Merit Medical Systems Recent Developments
- Table 43. CeloNova BioSciences Company Information
- Table 44. CeloNova BioSciences Business Overview
- Table 45. CeloNova BioSciences Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 46. CeloNova BioSciences Drug Eluting Beads Product Portfolio
- Table 47. CeloNova BioSciences Recent Developments
- Table 48. BTG International Company Information
- Table 49. BTG International Business Overview
- Table 50. BTG International Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 51. BTG International Drug Eluting Beads Product Portfolio
- Table 52. BTG International Recent Developments
- Table 53. Boston Scientific Company Information
- Table 54. Boston Scientific Business Overview
- Table 55. Boston Scientific Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 56. Boston Scientific Drug Eluting Beads Product Portfolio
- Table 57. Boston Scientific Recent Developments
- Table 58. Biocompatibles Company Information
- Table 59. Biocompatibles Business Overview
- Table 60. Biocompatibles Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 61. Biocompatibles Drug Eluting Beads Product Portfolio
- Table 62. Biocompatibles Recent Developments
- Table 63. ABK Biomedical Company Information
- Table 64. ABK Biomedical Business Overview
- Table 65. ABK Biomedical Drug Eluting Beads Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 66. ABK Biomedical Drug Eluting Beads Product Portfolio
- Table 67. ABK Biomedical Recent Developments
- Table 68. Global Drug Eluting Beads Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 69. Global Drug Eluting Beads Sales by Region (2020-2025) & (k units)
- Table 70. Global Drug Eluting Beads Sales Market Share by Region (2020-2025)
- Table 71. Global Drug Eluting Beads Sales by Region (2026-2031) & (k units)
- Table 72. Global Drug Eluting Beads Sales Market Share by Region (2026-2031)
- Table 73. Global Drug Eluting Beads Revenue by Region (2020-2025) & (US$ Million)
- Table 74. Global Drug Eluting Beads Revenue Market Share by Region (2020-2025)
- Table 75. Global Drug Eluting Beads Revenue by Region (2026-2031) & (US$ Million)
- Table 76. Global Drug Eluting Beads Revenue Market Share by Region (2026-2031)
- Table 77. North America Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 78. North America Drug Eluting Beads Sales by Country (2020-2025) & (k units)
- Table 79. North America Drug Eluting Beads Sales by Country (2026-2031) & (k units)
- Table 80. North America Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
- Table 81. North America Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
- Table 82. Europe Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. Europe Drug Eluting Beads Sales by Country (2020-2025) & (k units)
- Table 84. Europe Drug Eluting Beads Sales by Country (2026-2031) & (k units)
- Table 85. Europe Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
- Table 86. Europe Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Asia Pacific Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 88. Asia Pacific Drug Eluting Beads Sales by Country (2020-2025) & (k units)
- Table 89. Asia Pacific Drug Eluting Beads Sales by Country (2026-2031) & (k units)
- Table 90. Asia Pacific Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
- Table 91. Asia Pacific Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
- Table 92. South America Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 93. South America Drug Eluting Beads Sales by Country (2020-2025) & (k units)
- Table 94. South America Drug Eluting Beads Sales by Country (2026-2031) & (k units)
- Table 95. South America Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
- Table 96. South America Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
- Table 97. Middle East and Africa Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 98. Middle East and Africa Drug Eluting Beads Sales by Country (2020-2025) & (k units)
- Table 99. Middle East and Africa Drug Eluting Beads Sales by Country (2026-2031) & (k units)
- Table 100. Middle East and Africa Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
- Table 101. Middle East and Africa Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
- Table 102. Global Drug Eluting Beads Sales by Type (2020-2025) & (k units)
- Table 103. Global Drug Eluting Beads Sales by Type (2026-2031) & (k units)
- Table 104. Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
- Table 105. Global Drug Eluting Beads Sales Market Share by Type (2026-2031)
- Table 106. Global Drug Eluting Beads Revenue by Type (2020-2025) & (US$ Million)
- Table 107. Global Drug Eluting Beads Revenue by Type (2026-2031) & (US$ Million)
- Table 108. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
- Table 109. Global Drug Eluting Beads Revenue Market Share by Type (2026-2031)
- Table 110. Global Drug Eluting Beads Price by Type (2020-2025) & (US$/unit)
- Table 111. Global Drug Eluting Beads Price by Type (2026-2031) & (US$/unit)
- Table 112. Global Drug Eluting Beads Sales by Application (2020-2025) & (k units)
- Table 113. Global Drug Eluting Beads Sales by Application (2026-2031) & (k units)
- Table 114. Global Drug Eluting Beads Sales Market Share by Application (2020-2025)
- Table 115. Global Drug Eluting Beads Sales Market Share by Application (2026-2031)
- Table 116. Global Drug Eluting Beads Revenue by Application (2020-2025) & (US$ Million)
- Table 117. Global Drug Eluting Beads Revenue by Application (2026-2031) & (US$ Million)
- Table 118. Global Drug Eluting Beads Revenue Market Share by Application (2020-2025)
- Table 119. Global Drug Eluting Beads Revenue Market Share by Application (2026-2031)
- Table 120. Global Drug Eluting Beads Price by Application (2020-2025) & (US$/unit)
- Table 121. Global Drug Eluting Beads Price by Application (2026-2031) & (US$/unit)
- Table 122. Key Raw Materials
- Table 123. Raw Materials Key Suppliers
- Table 124. Drug Eluting Beads Distributors List
- Table 125. Drug Eluting Beads Customers List
- Table 126. Drug Eluting Beads Industry Trends
- Table 127. Drug Eluting Beads Industry Drivers
- Table 128. Drug Eluting Beads Industry Restraints
- Table 129. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Drug Eluting Beads Product Image
- Figure 5. Global Drug Eluting Beads Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Drug Eluting Beads Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Drug Eluting Beads Sales (2020-2031) & (k units)
- Figure 8. Global Drug Eluting Beads Average Price (US$/unit) & (2020-2031)
- Figure 9. LC Beads Product Image
- Figure 10. Quadra Sphere Product Image
- Figure 11. Oncozene Beads Product Image
- Figure 12. Others Product Image
- Figure 13. Specialized Clinics Product Image
- Figure 14. Hospitals Product Image
- Figure 15. Research Centers Product Image
- Figure 16. Ambulatory Surgical Centers Product Image
- Figure 17. Global Drug Eluting Beads Revenue Share by Manufacturers in 2024
- Figure 18. Global Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
- Figure 19. Global Top 5 and 10 Drug Eluting Beads Players Market Share by Revenue in 2024
- Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 21. Global Drug Eluting Beads Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 22. Global Drug Eluting Beads Sales by Region in 2024
- Figure 23. Global Drug Eluting Beads Revenue by Region in 2024
- Figure 24. North America Drug Eluting Beads Market Size by Country in 2024
- Figure 25. North America Drug Eluting Beads Sales Market Share by Country (2020-2031)
- Figure 26. North America Drug Eluting Beads Revenue Market Share by Country (2020-2031)
- Figure 27. United States Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Canada Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 29. Europe Drug Eluting Beads Market Size by Country in 2024
- Figure 30. Europe Drug Eluting Beads Sales Market Share by Country (2020-2031)
- Figure 31. Europe Drug Eluting Beads Revenue Market Share by Country (2020-2031)
- Figure 32. Germany Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. France Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. U.K. Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Italy Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Netherlands Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Asia Pacific Drug Eluting Beads Market Size by Country in 2024
- Figure 38. Asia Pacific Drug Eluting Beads Sales Market Share by Country (2020-2031)
- Figure 39. Asia Pacific Drug Eluting Beads Revenue Market Share by Country (2020-2031)
- Figure 40. China Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Japan Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. South Korea Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. India Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Australia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. China Taiwan Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Southeast Asia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. South America Drug Eluting Beads Market Size by Country in 2024
- Figure 49. South America Drug Eluting Beads Sales Market Share by Country (2020-2031)
- Figure 50. South America Drug Eluting Beads Revenue Market Share by Country (2020-2031)
- Figure 51. Mexico Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. Brazil Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. Argentina Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Middle East and Africa Drug Eluting Beads Market Size by Country in 2024
- Figure 55. Middle East and Africa Drug Eluting Beads Sales Market Share by Country (2020-2031)
- Figure 56. Middle East and Africa Drug Eluting Beads Revenue Market Share by Country (2020-2031)
- Figure 57. Turkey Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 58. Saudi Arabia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. UAE Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. Global Drug Eluting Beads Sales Market Share by Type (2020-2031)
- Figure 61. Global Drug Eluting Beads Revenue Market Share by Type (2020-2031)
- Figure 62. Global Drug Eluting Beads Price (US$/unit) by Type (2020-2031)
- Figure 63. Global Drug Eluting Beads Sales Market Share by Application (2020-2031)
- Figure 64. Global Drug Eluting Beads Revenue Market Share by Application (2020-2031)
- Figure 65. Global Drug Eluting Beads Price (US$/unit) by Application (2020-2031)
- Figure 66. Drug Eluting Beads Value Chain
- Figure 67. Drug Eluting Beads Production Mode & Process
- Figure 68. Direct Comparison with Distribution Share
- Figure 69. Distributors Profiles
- Figure 70. Drug Eluting Beads Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
